DIAMOND THERAPEUTICS
Diamond Therapeutics is a psychedelic drug development company based in Toronto. Our mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. Diamond is focused on sub-perceptual, non-hallucinogenic treatments that hold potential for use across a broad patient cohort — maximizing the positive impact better drugs can have on the global mental health crisis.
DIAMOND THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Medical Therapeutics
Founded:
2018-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.diamondthera.com
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Font Awesome Euro Google Apps For Business
Similar Organizations
BioHuntress Therapeutics
BioHuntress Therapeutics is a nature-inspired, scientifically validated, patent-protected drug development platform.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Pace Analytical Services
Pace Analytical is a leader in integrated drug development.
Current Advisors List
Advisor
2019-01-01
Board_member
Current Employees Featured
Judith Blumstock CEO and Founder @ Diamond Therapeutics
CEO and Founder
2018-01-01
David Brown Vice president, pharmaceutical development. @ Diamond Therapeutics
Vice president, pharmaceutical development.
Founder
Investors List
Ontario Brain Institute
Ontario Brain Institute investment in Venture Round - Diamond Therapeutics
Official Site Inspections
http://www.diamondthera.com Semrush global rank: 3.51 M Semrush visits lastest month: 4.21 K
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Diamond Therapeutics"
Diamond Therapeutics
Diamond Therapeutics is a psychedelic pharmaceutical company. We're developing safe, FDA, EMA and Health Canada approved therapies for neuropsychiatric conditions, starting with sub …See details»
Diamond Therapeutics - Crunchbase Company Profile …
Contact Email info@diamondthera.com Diamond Therapeutics is a psychedelic drug development company based in Toronto. Our mission is to develop new and better therapies for mental health conditions by unlocking the promise of …See details»
Diamond Therapeutics — New Index
For further information: Rebecca Brown, rebecca@diamondthera.comTORONTO, ... The World Health Organization estimates that depression affects more than 250 million people worldwide, …See details»
Building innovation in brain research & care - Ontario Brain Institute
Jan 7, 2021 To learn more about Diamond, visit us at www.diamondthera.com. About Ontario Brain Institute The Ontario Brain Institute is a not-for-profit organization that accelerates …See details»
Diamond Therapeutics - LinkedIn
Richard Boadway Chairman at Diamond Therapeutics and Past Chairman and President of Freeing the Human Spirit (a charity). Mentor to the CEO of Romaeris Corporation…See details»
Diamond Therapeutics Announces Health Canada Approval of
Jan 24, 2023 To learn more about Diamond, visit www.diamondthera.com. ... Organization Profile. Diamond Therapeutics Inc. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET …See details»
Ontario Brain Institute Increases Investment in Diamond
Jan 7, 2021 To learn more about Diamond, visit us at www.diamondthera.com. About Ontario Brain Institute The Ontario Brain Institute is a not-for-profit organization that accelerates …See details»
Ontario Brain Institute Increases Investment in Diamond …
To learn more about Diamond, visit us at www.diamondthera.com. About Ontario Brain Institute The Ontario Brain Institute is a not-for-profit organization that accelerates discovery and …See details»
Diamond Therapeutics contracts BioPharma Services for Phase
Jun 17, 2021 To learn more about Diamond, visit www.diamondthera.com. About BioPharma Services Inc. BioPharma Services Inc. is a full-service Contract Research Organization (CRO) …See details»
Diamond Therapeutics contracts BioPharma Services for Phase 1 …
Jun 17, 2021 To learn more about Diamond, visit www.diamondthera.com. About BioPharma Services Inc. BioPharma Services Inc. is a full-service Contract Research Organization (CRO) …See details»
Ontario Brain Institute Increases Investment in Diamond
Jan 7, 2021 To learn more about Diamond, visit us at www.diamondthera.com. About Ontario Brain Institute The Ontario Brain Institute is a not-for-profit organization that accelerates …See details»
Diamond Therapeutics Signs Agreement with McGill University for ...
Feb 4, 2021 The World Health Organization estimates that depression affects more than 250 million people worldwide, while anxiety is the most prevalent mental health disorder in the …See details»
Diamond Therapeutics Achieves Last Patient Last Visit in
Mar 29, 2022 To learn more about Diamond, visit www.diamondthera.com. ... Organization Profile. Diamond Therapeutics Inc. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET …See details»
Diamond Therapeutics Announces Four Critical Hires to Further ...
TORONTO, Nov. 30, 2021 /PRNewswire/ - Diamond Therapeutics Inc. (“Diamond”), a drug development company focused on low-dose psychedelic therapies for use in the treatment of …See details»
Diamond Therapeutics Announces First Patient Dosed in Health …
Nov 8, 2021 To learn more about Diamond, visit www.diamondthera.com. ... Organization Profile. Diamond Therapeutics Inc. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET …See details»
Diamond Therapeutics contracts BioPharma Services for Phase 1 …
Jun 17, 2021 To learn more about Diamond, visit www.diamondthera.com. About BioPharma Services Inc. BioPharma Services Inc. is a full-service Contract Research Organization (CRO) …See details»
Ontario Brain Institute Increases Investment in Diamond …
TORONTO, Jan. 7, 2021 /PRNewswire/ – Emerging psychedelic drug development company Diamond Therapeutics has received new investment from the Ontario Brain Institute (OBI), a …See details»
Diamond Therapeutics Announces First Patient Dosed in Clinical …
Nov 8, 2021 The trial is being conducted in Toronto under the supervision of principal investigator Dr. Isabella Szeto of BioPharma Services Inc., the contract research organization …See details»
Diamond Therapeutics Announces Four Critical Hires to Further ...
TORONTO, Nov. 30, 2021 /CNW/ - Diamond Therapeutics Inc. ("Diamond"), a drug development company focused on low-dose psychedelic therapies for use in the treatment of mental health, …See details»
Diamond Therapeutics Announces Health Canada Approval of
TORONTO, Aug. 17, 2021 /CNW/ - Diamond Therapeutics Inc. ("Diamond"), a drug development company focused on low-dose psychedelic therapies for use in the treatment of mental health, …See details»